BOOST Pharma
Phase 1/2Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2M
About
Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
Cell & Gene Therapy
Funding History
2Total raised:$2M
Grant$500KSep 15, 2017
Seed$1.5MJun 15, 2016